302 related articles for article (PubMed ID: 12969142)
21. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
[TBL] [Abstract][Full Text] [Related]
22. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
23. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
24. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
Suzuki T; Iyoda M; Shibata T; Ohtaki H; Matsumoto K; Shindo-Hirai Y; Kuno Y; Wada Y; Yamamoto Y; Kawaguchi M; Shioda S; Akizawa T
PLoS One; 2013; 8(6):e67475. PubMed ID: 23826305
[TBL] [Abstract][Full Text] [Related]
26. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis.
Morath C; Dechow C; Lehrke I; Haxsen V; Waldherr R; Floege J; Ritz E; Wagner J
J Am Soc Nephrol; 2001 Nov; 12(11):2300-2309. PubMed ID: 11675406
[TBL] [Abstract][Full Text] [Related]
27. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
[TBL] [Abstract][Full Text] [Related]
28. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
Tang WW; Feng L; Vannice JL; Wilson CB
J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
[TBL] [Abstract][Full Text] [Related]
30. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis.
Iyoda M; Shibata T; Wada Y; Kuno Y; Shindo-Hirai Y; Matsumoto K; Akizawa T
Nephrol Dial Transplant; 2013 Mar; 28(3):576-84. PubMed ID: 23045430
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats.
Lai PC; Cook HT; Smith J; Keith JC; Pusey CD; Tam FWK
J Am Soc Nephrol; 2001 Nov; 12(11):2310-2320. PubMed ID: 11675407
[TBL] [Abstract][Full Text] [Related]
32. Isotretinoin alleviates renal damage in rat chronic glomerulonephritis.
Schaier M; Lehrke I; Schade K; Morath C; Shimizu F; Kawachi H; Grone HJ; Ritz E; Wagner J
Kidney Int; 2001 Dec; 60(6):2222-34. PubMed ID: 11737596
[TBL] [Abstract][Full Text] [Related]
33. Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis.
Saga D; Sakatsume M; Ogawa A; Tsubata Y; Kaneko Y; Kuroda T; Sato F; Ajiro J; Kondo D; Miida T; Narita I; Gejyo F
Kidney Int; 2005 May; 67(5):1821-9. PubMed ID: 15840029
[TBL] [Abstract][Full Text] [Related]
34. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
[TBL] [Abstract][Full Text] [Related]
35. Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis.
Peters H; Border WA; Noble NA
Kidney Int; 2000 Mar; 57(3):992-1001. PubMed ID: 10720952
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effects.
Tachibana S; Iyoda M; Matsumoto K; Wada Y; Suzuki T; Iseri K; Kanazawa N; Shibata T
Nephrol Dial Transplant; 2019 May; 34(5):774-782. PubMed ID: 29982644
[TBL] [Abstract][Full Text] [Related]
37. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
38. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis.
Yuan HT; Tipping PG; Li XZ; Long DA; Woolf AS
Kidney Int; 2002 Jun; 61(6):2078-89. PubMed ID: 12028448
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid can regulate the expressions of gelatinases and apolipoprotein E in glomerulosclerosis rats.
Zhou TB; Qin YH; Ou C; Lei FY; Su LN; Huang WF; Zhao YJ
Vascul Pharmacol; 2011; 55(5-6):169-77. PubMed ID: 21907828
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis.
Abraham AP; Ma FY; Mulley WR; Nikolic-Paterson DJ; Tesch GH
Nephrology (Carlton); 2018 Feb; 23(2):183-189. PubMed ID: 27862656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
